Literature DB >> 33923293

Cytokine Biosignature of Active and Latent Mycobacterium Tuberculosis Infection in Children.

Magdalena Druszczynska1, Michal Seweryn2, Sebastian Wawrocki1, Magdalena Kowalewska-Pietrzak3, Anna Pankowska3, Wieslawa Rudnicka1.   

Abstract

None of the currently used diagnostic tools are efficient enough in diagnosing Mycobacterium tuberculosis (M.tb) infection in children. The study was aimed to identify cytokine biosignatures characterizing active and latent tuberculosis (TB) in children. Using a multiplex bead-based technology, we analyzed the levels of 53 Th17-related cytokines and inflammatory mediators in sera from 216 BCG-vaccinated children diagnosed with active TB (TB) or latent TB (LTBI) as well as uninfected controls (HC). Children with active TB, compared to HC children, showed reduced serum levels of IL-17A, MMP-2, OPN, PTX-3, and markedly elevated concentrations of APRIL/TNFSF13. IL-21, sCD40L, MMP-2, and IL-8 were significantly differentially expressed in the comparisons between groups: (1) HC versus TB and LTBI (jointly), and (2) TB versus LTBI. The panel consisting of APRIL/TNFSF13, sCD30/TNFRSF8, IFN-α2, IFN-γ, IL-2, sIL-6Rα, IL-8, IL-11, IL-29/IFN-λ1, LIGHT/TNFSF14, MMP-1, MMP-2, MMP-3, osteocalcin, osteopontin, TSLP, and TWEAK/TNFSF12 possessed a discriminatory potential for the differentiation between TB and LTBI children. Serum-based host biosignatures carry the potential to aid the diagnosis of childhood M.tb infections. The proposed panels of markers allow distinguishing not only children infected with M.tb from uninfected individuals but also children with active TB from those with latent TB.

Entities:  

Keywords:  cytokines; diagnostics; latent Mycobacterium tuberculosis infection; tuberculosis

Year:  2021        PMID: 33923293     DOI: 10.3390/pathogens10050517

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  61 in total

Review 1.  Diagnosing childhood tuberculosis: traditional and innovative modalities.

Authors:  Jennifer Lighter; Mona Rigaud
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2009-03

Review 2.  IL-17 and IFN-γ production in peripheral blood following BCG vaccination and Mycobacterium tuberculosis infection in human.

Authors:  Q Li; J Li; J Tian; B Zhu; Y Zhang; K Yang; Y Ling; Y Hu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-12       Impact factor: 3.507

3.  The assessment of cytokines in Quantiferon supernatants for the diagnosis of latent TB infection in a tribal population of Melghat, India.

Authors:  Prachi R Bapat; Aliabbas A Husain; Hatim F Daginawala; Neha P Agrawal; Milind S Panchbhai; Ashish R Satav; Girdhar M Taori; Rajpal S Kashyap
Journal:  J Infect Public Health       Date:  2015-03-29       Impact factor: 3.718

4.  Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.

Authors:  E Matsuura; F Umehara; T Hashiguchi; N Fujimoto; Y Okada; M Osame
Journal:  J Neurol Sci       Date:  2000-02-01       Impact factor: 3.181

5.  Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

Authors:  A K Detjen; T Keil; S Roll; B Hauer; H Mauch; U Wahn; K Magdorf
Journal:  Clin Infect Dis       Date:  2007-06-15       Impact factor: 9.079

6.  Evaluation of Interleukin17and Interleukin 23 expression in patients with active and latent tuberculosis infection.

Authors:  Fatemeh Heidarnezhad; Amir Asnaashari; Seyed Abdolrahim Rezaee; Roghayeh Ghezelsofla; Kiarash Ghazvini; Narges Valizadeh; Reza Basiri; Aghigh Ziaeemehr; Somayeh Sobhani; Houshang Rafatpanah
Journal:  Iran J Basic Med Sci       Date:  2016-08       Impact factor: 2.699

7.  Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response.

Authors:  Ruschca Jacobs; Stephanus Malherbe; Andre G Loxton; Kim Stanley; Gian van der Spuy; Gerhard Walzl; Novel N Chegou
Journal:  Oncotarget       Date:  2016-09-06

8.  Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting.

Authors:  Eva L Sudbury; Larissa Otero; Marc Tebruegge; Nicole L Messina; Carlos Seas; Martin Montes; Julia Rìos; Susie Germano; Kaya Gardiner; Vanessa Clifford; Eduardo Gotuzzo; Nigel Curtis
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-04-25

9.  Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.

Authors:  Novel N Chegou; Jayne S Sutherland; Stephanus Malherbe; Amelia C Crampin; Paul L A M Corstjens; Annemieke Geluk; Harriet Mayanja-Kizza; Andre G Loxton; Gian van der Spuy; Kim Stanley; Leigh A Kotzé; Marieta van der Vyver; Ida Rosenkrands; Martin Kidd; Paul D van Helden; Hazel M Dockrell; Tom H M Ottenhoff; Stefan H E Kaufmann; Gerhard Walzl
Journal:  Thorax       Date:  2016-05-04       Impact factor: 9.139

10.  ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions.

Authors:  Wen-Yeh Hsieh; Tang-Ching Kuan; Kun-Shan Cheng; Yan-Chiou Liao; Mu-Yuan Chen; Pei-Heng Lin; Yuan-Chang Hsu; Chen-Yi Huang; Wei-Hua Hsu; Sheng-Yao Yu; Chih-Sheng Lin
Journal:  Int J Biol Sci       Date:  2012-10-17       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.